| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/08/2005 | US6864248 Androgenic steroid compounds and a method of making and using the same |
| 03/08/2005 | US6862890 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 03/08/2005 | CA2480712A1 Chondrocyte therapeutic delivery system |
| 03/03/2005 | WO2005019188A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | WO2005018660A1 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 03/03/2005 | WO2005018636A1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivative as estrogenic agents |
| 03/03/2005 | WO2005000883A8 Polypeptides having binding affinity for insulin |
| 03/03/2005 | US20050049293 Increasing effect of released acetylcholine on hepatic muscarinic receptors |
| 03/03/2005 | US20050049290 Benzimidazole derivatives and their use as gnrh antagonists |
| 03/03/2005 | US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049231 Local delivery of aromatase inhibitor using intravaginal device; estrogen dependent proliferative disorders of uterus; minimal side effects, longer term treatment, variable dosage |
| 03/03/2005 | US20050049186 Peptides mimicking the biological activity of steroid hormones and their uses |
| 03/03/2005 | US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells |
| 03/03/2005 | CA2536313A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | CA2535341A1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivative as estrogenic agents |
| 03/02/2005 | EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 03/02/2005 | EP1509612A2 Transcellular drug delivery system |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509518A1 Calcium receptor modulating agents |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/01/2005 | US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | US20050043788 Drug-eluting stent |
| 02/24/2005 | US20050043387 Tricyclic indole compounds having an affinity against serotonin receptors |
| 02/24/2005 | US20050043362 Use of compounds |
| 02/24/2005 | US20050043350 Administering heterocyclic ether such as 5-chloro-7-hydroxy-3-(4-hydroxyphenylz)-4-oxo-1-benzopyran for prophylaxis of Alzheimer's disease, osteoporosis, cardiovascular disorders, psychological disorders, antiarthritic agents,anxiolytic agents |
| 02/24/2005 | US20050043338 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/24/2005 | US20050043285 Formulation |
| 02/24/2005 | US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050043242 Using dietary restriction to lower serum insulin levels and function along with troglitazone in treatment and prevention of alzheimer's diseases |
| 02/24/2005 | US20050043231 Therapy for growth hormone induced insulin resistance in juveniles with growth disorders |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042279 Pharmaceutical formulation comprising more than 15% tamoxifen |
| 02/24/2005 | US20050042173 Pharmaceuticals, cosmetics or nutraceuticals with a bioadhesive and plasticizer on a biodegradable support for transdermal or transmucosal application |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/24/2005 | CA2535156A1 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 02/23/2005 | EP1507800A1 Use of monocarboxylate transporter protein for thyroid hormone transport |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507538A1 Norethindrone sustained release formulations and methods associated therewith |
| 02/23/2005 | EP1507537A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1507525A1 Non-steroidal anti-androgen therapy |
| 02/23/2005 | EP1507514A2 Controlled release compositions of estradiol metabolites |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1066304B1 Macrolide lhrh antagonists |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585900A Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin |
| 02/23/2005 | CN1585751A 喹啉化合物 Quinoline compound |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585644A Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 02/23/2005 | CN1583105A Chinese medicinal composition and its preparation and quality control |
| 02/23/2005 | CN1190425C Six kinds of isoquinoline alkaloid |
| 02/22/2005 | US6858642 For use in pharmaceutical, skin-protective and cosmetic formulations |
| 02/22/2005 | US6858640 Tricyclic indole compounds having affinity for serotonin receptor |
| 02/22/2005 | US6858629 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858603 Acetindine derivatives, their preparation and medicaments containing them |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 02/22/2005 | US6858580 Immobilization of drugs |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/17/2005 | WO2005014591A1 2-acylamino or 2-sulfonylamino-1, 3-thiazoles as couplers for the oxidation dyeing of keratin fibres |
| 02/17/2005 | WO2005013938A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 02/17/2005 | WO2004099122A3 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 02/17/2005 | WO2004093781A3 Podophyllotoxin derivatives as igf-1r inhibitors |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038107 Substituted 2-phenyl benzofurans as estrogenic agents |
| 02/17/2005 | US20050038061 6-Aminomorphinane derivatives, method for production and use thereof |
| 02/17/2005 | US20050038057 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; utility in treatment of a variety of sex-hormone related conditions in both men and women |
| 02/17/2005 | US20050038056 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050037074 Treating adrenal dysfunction in a patient by administering a pharmaceutically effective amount of a combined glucocorticoid such as hydrocortisone and a delivery vehicle, wherein delivery vehicle provides for delayed and sustained release of glucorticoid; congenital adrenal hyperplasia |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050036985 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/17/2005 | US20050035267 Furnace mount and method of installation |
| 02/17/2005 | US20050035266 Furnace Mount and Method of Installation |
| 02/17/2005 | DE10335027A1 Use of telmisartan and simvastatin for treatment or prophylaxis of cardiovascular, cardiopulmonary and renal diseases e.g. hypertension combined with hyperlipidemia or atherosclerosis |
| 02/17/2005 | CA2534471A1 Method and apparatus for producing ultrafine drug particles |
| 02/16/2005 | EP1506999A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |